Infographic: Efficacy and Safety of High-Dose Intravitreal Aflibercept 8 mg in Patients with Treatment-Naïve Neovascular Age-Related Macular Degeneration: Week 96 Results from the Phase 3 PULSAR Trial

PubMed ID: 42162248 Author(s): Korobelnik JF, Leal S, Lanzetta P; PULSAR study investigators. Infographic: Efficacy and Safety of High-Dose Intravitreal Aflibercept 8 mg in Patients with Treatment-Naïve Neovascular Age-Related Macular Degeneration: Week 96 Results from the …

Impact of Aflibercept Dosing Frequency on Retinal Nonperfusion Progression Assessed by Ultra-Widefield Angiography After Endolaserless Vitrectomy for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage.

PubMed ID: 42164908 Author(s): Qin LG, Camarda ND, Kasetty VM, Starnes DC, Sood N, Blodi BA, Marcus DM. Impact of Aflibercept Dosing Frequency on Retinal Nonperfusion Progression Assessed by Ultra-Widefield Angiography After Endolaserless Vitrectomy for …